Atari SA (LON:0KUV)
London · Delayed Price · Currency is GBP · Price in EUR 0.1445
+0.0020 (1.40%)
At close: Aug 1, 2025
Intercept Pharmaceuticals Balance Sheet
Financials in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 3.5 | 2.6 | 1.7 | 0.6 | 2.5 | Upgrade |
Cash & Short-Term Investments | 3.5 | 2.6 | 1.7 | 0.6 | 2.5 | Upgrade |
Cash Growth | 34.62% | 52.94% | 183.33% | -76.00% | 38.89% | Upgrade |
Accounts Receivable | 4.6 | 4.1 | 3.1 | 2.4 | 3.2 | Upgrade |
Other Receivables | - | - | - | - | 0.2 | Upgrade |
Receivables | 4.6 | 4.1 | 3.1 | 2.4 | 3.4 | Upgrade |
Inventory | 0.9 | 0.7 | 0.5 | 2.1 | 2.5 | Upgrade |
Prepaid Expenses | - | 2.6 | 1.8 | 1.7 | 0.2 | Upgrade |
Other Current Assets | 6.8 | - | - | 0.2 | 0.5 | Upgrade |
Total Current Assets | 15.8 | 10 | 7.1 | 7 | 9.1 | Upgrade |
Property, Plant & Equipment | 1.2 | 1.8 | 1.3 | 1.6 | 1.9 | Upgrade |
Long-Term Investments | - | 12.3 | 7.9 | 9.2 | 15.9 | Upgrade |
Goodwill | 18.2 | 28.7 | - | - | - | Upgrade |
Other Intangible Assets | 27.3 | 24.1 | 7.7 | 6.1 | 11.6 | Upgrade |
Long-Term Deferred Tax Assets | 1.3 | 1.2 | 1.2 | 2 | 1.9 | Upgrade |
Other Long-Term Assets | 13.3 | - | - | 0.1 | - | Upgrade |
Total Assets | 77.1 | 78.1 | 25.2 | 26 | 40.4 | Upgrade |
Accounts Payable | 6.1 | 4.3 | 2.7 | 8.2 | 7.3 | Upgrade |
Accrued Expenses | - | - | 2.1 | - | - | Upgrade |
Short-Term Debt | 10 | - | - | - | - | Upgrade |
Current Portion of Long-Term Debt | - | 5.3 | 0.2 | 0.1 | - | Upgrade |
Current Portion of Leases | 0.6 | 0.6 | 0.4 | 0.4 | 0.3 | Upgrade |
Current Income Taxes Payable | 0.5 | - | - | - | - | Upgrade |
Current Unearned Revenue | - | - | 2.4 | 2.4 | - | Upgrade |
Other Current Liabilities | 4.7 | 3.6 | 0.1 | 2.5 | 6.3 | Upgrade |
Total Current Liabilities | 21.9 | 13.8 | 7.9 | 13.6 | 13.9 | Upgrade |
Long-Term Debt | 42.8 | 38.9 | 7.7 | 5 | - | Upgrade |
Long-Term Leases | 0.6 | 1.3 | 1 | 1.3 | 1.6 | Upgrade |
Other Long-Term Liabilities | 13.7 | 17.3 | 0.8 | 1.7 | 0.7 | Upgrade |
Total Liabilities | 79 | 71.3 | 17.4 | 21.6 | 16.2 | Upgrade |
Common Stock | 4.6 | 4.4 | 3.8 | 3.1 | 3 | Upgrade |
Additional Paid-In Capital | 45 | 43.1 | 32.7 | 21.4 | 19.1 | Upgrade |
Retained Earnings | -12.6 | -13.5 | -9.5 | -23.8 | -11.9 | Upgrade |
Comprehensive Income & Other | -38.9 | -27.2 | -19.2 | 3.7 | 14 | Upgrade |
Total Common Equity | -1.9 | 6.8 | 7.8 | 4.4 | 24.2 | Upgrade |
Shareholders' Equity | -1.9 | 6.8 | 7.8 | 4.4 | 24.2 | Upgrade |
Total Liabilities & Equity | 77.1 | 78.1 | 25.2 | 26 | 40.4 | Upgrade |
Total Debt | 54 | 46.1 | 9.3 | 6.8 | 1.9 | Upgrade |
Net Cash (Debt) | -50.5 | -43.5 | -7.6 | -6.2 | 0.6 | Upgrade |
Net Cash Per Share | -0.08 | -0.10 | -0.02 | -0.02 | 0.00 | Upgrade |
Filing Date Shares Outstanding | 463.16 | 439.55 | 418.39 | 306.03 | 298.63 | Upgrade |
Total Common Shares Outstanding | 463.16 | 439.15 | 382.53 | 306.03 | 298.63 | Upgrade |
Working Capital | -6.1 | -3.8 | -0.8 | -6.6 | -4.8 | Upgrade |
Book Value Per Share | -0.00 | 0.02 | 0.02 | 0.01 | 0.08 | Upgrade |
Tangible Book Value | -47.4 | -46 | 0.1 | -1.7 | 12.6 | Upgrade |
Tangible Book Value Per Share | -0.10 | -0.10 | 0.00 | -0.01 | 0.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.